Article Information
History
- August 13, 2024.
Article Versions
- Version 1 (August 8, 2024 - 11:28).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Vera Fominykh1,*,
- Alexey A. Shadrin1,2,**,
- Piotr Jaholkowski1,**,
- Julian Fuhrer1,
- Nadine Parker1,
- Erik D. Wiström3,
- Oleksandr Frei1,3,
- Olav B. Smeland1,3,
- Helga Sanner4,5,
- Srdjan Djurovic1,2,6 and
- Ole A. Andreassen1,2,3
- 1Centre for Precision Psychiatry, Institute of Clinical Medicine, University of Oslo, Oslo, Norway
- 2K.G. Jebsen Centre for Neurodevelopmental Disorders, University of Oslo and Oslo University Hospital, Oslo, Norway
- 3Section for Precision Psychiatry, Oslo University Hospital, Oslo, Norway
- 4Department of Rheumatology, Oslo University Hospital, Oslo, Norway
- 5Oslo New University College, Oslo, Norway
- 6Department of Medical Genetics, Oslo University Hospital, Oslo, Norway
- ↵*Corresponding author vera.fominykh{at}medisin.uio.no
↵** contributed equally to this manuscript
Posted August 13, 2024.
Mapping the genetic landscape of disorders on the autoimmune-autoinflammatory continuum: potential implications for classification and treatment
